Nephros Inc
NEPH
Get informed when a big investor buys or sells
+ FollowMarket Cap$39.41M
Close$
$-2.34
165.9% downside
Current Fair Value
165.9% downsideOvervalued by 165.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $39.41 Million |
|---|---|
| Enterprise Value | $36.36 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.11 |
| Beta | 1.49 |
| Outstanding Shares | 10,650,819 |
Return
| Return on Equity | 7.25% |
|---|---|
| Return on Assets | 5.63% |
| Return on Invested Capital | 6.34% |
Valuation & Multiples
| P/E Ratio | 49.66 |
|---|---|
| PEG | -66.29 |
| Price to Sales | 3.55 |
| Price to Book Ratio | 3.55 |
| Enterprise Value to Revenue | 1.9 |
| Enterprise Value to EBIT | 50.92 |
| Enterprise Value to Net Income | 46 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.09 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 7, 2026
EPS Estimate
$0.01
Average shareholder expectationRevenue Estimate
$5.02 M
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$-0.01
Average shareholder expectationRevenue Estimate
$5.05 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 50.60%▲ 0.64% |
|---|---|
| Total Invested | $16.00M▼ 38.15% |
| Investors Holding | 27▼ 8.00% |
ESG Score
No data